High plasma cholesterol and diabetes are major risk factors for atherosclerosis. We have shown in mouse models that lowering cholesterol levels promotes macrophage emigration and regression of atherosclerosis. This is mediated in vivo by the induction of the chemokine receptor CCR7 via LXR?. Moreover, regression of atherosclerosis and expression of CCR7 are impaired in diabetic mice. We have recently found that phosphorylation of S198 of LXR? is high in progressing atherosclerotic plaques and in vitro decreases CCR7 transcription.Therefore, we propose that changes in plasma cholesterol and glucose levels are important modulators of LXR? gene expression through changes in LXR? phosphorylation at S198. To test this will we take an integrated systems biology approach combining powerful mouse models of atherosclerosis regression with sophisticated genomics approaches to elucidate mechanisms of LXR?-mediated gene regulation in atherosclerosis and diabetes. Insights from these basic studies will inform new approaches to treating atherosclerosis, particularly in diabetics.

Public Health Relevance

Patients with diabetes have a number of complications including cardiovascular disease (CVD). In fact; high cholesterol and high glucose are recognized risk factors for CVD. Using powerful mouse and cell culture models; coupled with state of the art genomic approaches; we will examine the effects of high cholesterol and high glucose on the action in macrophages; the building blocks of atherosclerotic plaques; of the nuclear receptor LXR ; which protects these cells against adverse effects of high cholesterol and glucose. Understanding the mechanisms whereby cholesterol and glucose impact LXR gene regulatory functions will inform new approaches for treating diabetes and atherosclerosis.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
1R01HL117226-01A1
Application #
8653403
Study Section
Molecular and Cellular Endocrinology Study Section (MCE)
Program Officer
Liu, Lijuan
Project Start
2013-12-23
Project End
2017-11-30
Budget Start
2013-12-23
Budget End
2014-11-30
Support Year
1
Fiscal Year
2014
Total Cost
$484,266
Indirect Cost
$172,035
Name
New York University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
121911077
City
New York
State
NY
Country
United States
Zip Code
10016
Shrestha, Elina; Hussein, Maryem A; Savas, Jeffery N et al. (2016) Poly(ADP-ribose) Polymerase 1 Represses Liver X Receptor-mediated ABCA1 Expression and Cholesterol Efflux in Macrophages. J Biol Chem 291:11172-84
Ouimet, Mireille; Hennessy, Elizabeth J; van Solingen, Coen et al. (2016) miRNA Targeting of Oxysterol-Binding Protein-Like 6 Regulates Cholesterol Trafficking and Efflux. Arterioscler Thromb Vasc Biol 36:942-51
Fisher, Edward A (2016) Regression of Atherosclerosis: The Journey From the Liver to the Plaque and Back. Arterioscler Thromb Vasc Biol 36:226-35
Savic, Daniel; Ramaker, Ryne C; Roberts, Brian S et al. (2016) Distinct gene regulatory programs define the inhibitory effects of liver X receptors and PPARG on cancer cell proliferation. Genome Med 8:74
Zhang, Xue-Qing; Even-Or, Orli; Xu, Xiaoyang et al. (2015) Nanoparticles containing a liver X receptor agonist inhibit inflammation and atherosclerosis. Adv Healthc Mater 4:228-36
Wu, Chaowei; Hussein, Maryem A; Shrestha, Elina et al. (2015) Modulation of Macrophage Gene Expression via Liver X Receptor α Serine 198 Phosphorylation. Mol Cell Biol 35:2024-34
Hussein, Maryem A; Shrestha, Elina; Ouimet, Mireille et al. (2015) LXR-Mediated ABCA1 Expression and Function Are Modulated by High Glucose and PRMT2. PLoS One 10:e0135218
Willecke, Florian; Yuan, Chujun; Oka, Kazuhiro et al. (2015) Effects of High Fat Feeding and Diabetes on Regression of Atherosclerosis Induced by Low-Density Lipoprotein Receptor Gene Therapy in LDL Receptor-Deficient Mice. PLoS One 10:e0128996
Williams, Kevin Jon; Tabas, Ira; Fisher, Edward A (2015) How an artery heals. Circ Res 117:909-13
Distel, Emilie; Barrett, Tessa J; Chung, Kellie et al. (2014) miR33 inhibition overcomes deleterious effects of diabetes mellitus on atherosclerosis plaque regression in mice. Circ Res 115:759-69

Showing the most recent 10 out of 11 publications